Loading...

GLS Glenmark Life Sciences Ltd Earnings Reports Announcement

Glnm

GLS

Glenmark Life Sciences Ltd

(GLS)

2024 Announcement

Show Summary

Summary

Newspaper Publication

Investor Meeting

Investor Meeting

USFDA Inspection Success

Earnings Call Transcript

Investor Meeting

Earnings Call Update

Investor Presentation

Q4 FY25 Results

Secretarial Auditor Appoint...

Directorate Change

Earnings Call Scheduled

Annual Compliance Report

Equity Shares Allotment

FDA Inspection Report

Share Acquisition Agreement

Investor Meeting

Director's Demise

GST Order Disclosure

Investor Meeting

USFDA Inspection Update

Earnings Call Transcript

Investor Meetings

Earnings Call Recording

Investor Presentation

Strong Q3 Results

Rebranding Announcement

Earnings Call Scheduled

Investor Meeting

Investor Meetings Planned

Earnings Call Transcript

Investor Meetings

Postal Ballot Notice

Investor Meetings

Earnings Call Recording

Q2 FY25 Presentation

Q2 Results Release

Equity Share Allotment

Promoter Reclassification

Earnings Call Scheduled

Earnings Call Scheduled

Tax Order Notice

Investor Meetings

AGM Announcement

Investor Meetings

AGM Announcement

Investor Meetings

Investor Meetings

GPCB Revocation Letter

IPO Proceeds Utilization Re...

Investor Meeting Intimation

Investor Meeting

Compliance with Minimum Pub...

Closure Notice for Ankleshw...

Earnings Call Outcome

Investor Presentation

Financial Results Announcement

Earnings Call Notification

Minimum Public Shareholding

Investor Meeting

Rating Outlook Revised to P...

Meeting Intimation

Analyst Meet Intimation

Investor Conference

Meeting Intimation

Meeting Intimation

Monitoring Report

Compliance Update

Newspaper Publication

Earnings Conference Call Tr...

Directorate Change

Directorate Change

Earnings Report

Financial Results Announcement

Director Resignation

Certificate Submission

Compliance Certificate Subm...

Reclassification Application

acquisition of stake

Equity Share Transfer

Investor Presentation

Investor Conferences

Appointment of Directors

New Promoter Designation

Sale of Equity Shares

Monitoring Agency Report

Recommendations of Committe...

Open Offer for Acquisition ...

Earnings Call Recording

Investor Presentation

Financial Results

CDMO deal with Japanese com...

Volume Clarification

Quarterly Earnings

Investor Presentation

Financial Results

TDS on Dividend Income

Open Offer for Acquisition

Credit Rating Watch

Open Offer for Acquisition

Rating Withdrawal

Newspaper Publication

Newspaper Advertisement for...

Monitoring Agency Report

Speculation Clarification

Financial Statements

Financial Statements

Financial Statements

Compliance Report

Report Submission

External Links:

Data:

Glenmark Life Sciences reported Q2FY25 revenue of Rs. 5,069 Mn and a gross margin of 55.6%, with expectations for better performance in H2FY25 despite prior setbacks.

AI Assistant

Glenmark Life Sciences Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.